ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,023.43
-0.24%
Dow Jones
37,952.20
0.36%
US Dollar vs MXN
17.02885
-0.72%
Brent Oil
83.635
-2.63%
Bitcoin
56,925.33
-6.06%
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Estados Unidos
  5. NASDAQ
  6. 23andMe Holding Company (ME)

  7. 23andMe Holding Company (ME) Noticias

ME 23andMe Holding Company

0.5166
0.0144 (2.87%)
Última actualización: 10:57:47
Retrasado por 15 minutos
Nombre de la Acción Símbolo de la Acción Bolsa de Valores Tipo de Valor
23andMe Holding Company ME NASDAQ Acción Común
  Variación del Día (ptos.) Variación del Día (%) Último Precio Hora
Upgrade Icon
0.0144 2.87% 0.5166 10:57:47
Precio de Apertura Precio Mínimo Precio Máximo Precio de cierre Precio Anterior
0.5082 0.4931 0.5288 0.5022
más cotizaciones de acciones »

Noticias Recientes

Fecha Hora Fuente Noticia
30/4/202410:00BWPotter Handy Law Firm Represents Nearly 5,000 Clients in..
24/4/202415:05GLOBE23andMe to Present Preliminary Efficacy and Biomarker Data..
18/4/202407:00GLOBE23andMe announces CEO’s intention to pursue a potential..
05/4/202415:05GLOBE23andMe to Present Data on Two Clinical Stage..
20/3/202406:30GLOBE23andMe Initiates Phase 1 Clinical Trial for its Dual..
19/3/202407:00GLOBE23andMe Launches New Feature Connecting Customers to..
06/3/202406:30GLOBE23andMe Launches New Genetic Reports on Common Forms of..
05/3/202415:30GLOBE23andMe Announces Three Presentations from Clinical-Stage..
21/2/202415:36EDGAR2Form 4 - Statement of changes in beneficial ownership of..
07/2/202415:07EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
07/2/202415:03EDGAR2Form 8-K - Current report
07/2/202415:01GLOBE23andMe Reports Third Quarter Fiscal 2024 Financial Results
06/2/202406:00BWMoneta Gold and Nighthawk Gold Complete At-Market Merger to..
31/1/202406:50EDGAR2Form 8-K - Current report
30/1/202421:12GLOBE23andMe Launches Month-Long Initiative to Amplify ARRAY’s..
30/1/202416:00BWNighthawk Gold Obtains Final Court Order for the Proposed..
24/1/202415:05GLOBE23andMe to Report FY2024 Third Quarter Financial Results
22/1/202407:00BWMoneta Gold and Nighthawk Gold Announce the Proposed..
08/1/202406:45EDGAR2Form 8-K - Current report
19/12/202307:00GLOBE23andMe announces further expansion of 23ME-00610 Phase 1/2a..
01/12/202315:06EDGAR2Form 8-K/A - Current report: [Amend]
28/11/202306:15BWNighthawk and Moneta Announce At-Market Merger to Create a..
21/11/202315:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/11/202315:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
13/11/202315:06EDGAR2Form 8-K - Current report
08/11/202315:29EDGAR2Form 8-K - Current report
08/11/202315:05GLOBE23andMe Reports Second Quarter Fiscal 2024 Financial Results
07/11/202307:00GLOBE23andMe Launches Total Health™, its..
06/11/202307:15EDGAR2Form 8-K - Current report
06/11/202307:00GLOBE23andMe Announces Updated Safety and Preliminary Efficacy..
31/10/202307:00GLOBE23andMe Launches Health Action Plan to Provide Personalized..
30/10/202315:05EDGAR2Form 8-K - Current report
30/10/202307:00GLOBE23andMe Announces Collaboration Extension with a New Data..
27/10/202315:06EDGAR2Form 8-K - Current report
25/10/202315:05GLOBE23andMe to Report FY2024 Second Quarter Financial Results
10/10/202315:17EDGAR2Form 8-K - Current report
27/9/202315:05GLOBE23andMe Announces Poster Presentations on 23ME-00610, an..
19/9/202315:15EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:14EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
19/9/202315:06EDGAR2Form 8-K - Current report
15/9/202315:06EDGAR2Form S-8 - Securities to be offered to employees in employee..
14/9/202306:00GLOBE23andMe and Sickle Cell 101 Collaborate to Expand Sickle..
11/9/202315:06EDGAR2Form 8-K - Current report
08/9/202315:55EDGAR2Form 4 - Statement of changes in beneficial ownership of..
08/9/202315:54EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/9/202316:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202317:30EDGAR2Form 144 - Report of proposed sale of securities
31/8/202316:28GLOBE23andMe Granted New FDA Clearance to Report Additional BRCA..
22/8/202315:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..

Su Consulta Reciente

NASDAQ
ME
23andMe
Delayed Upgrade Clock
ADVFN Logo

México
Empresa
Negocios
Popular
Obtener la aplicación

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados